These facts are updated till 11 May 2024, and are based on Volza's Export Import data India Export data of Doxilyd, sourced from 70 countries export import shipments with names of buyers, suppliers, top decision maker's contact information like phone, email and LinkedIn profiles.
HSN Code | Product Description | Origin | Destination | Qty. | Importer | Exporter |
---|
29331990 | HYDROCHLORIDE >> DOXORUBICIN HYDROCHLORIDEFOR DOXILYD 50 MG DOXORUBICIN HYDROCHLORIDEFOR INJ USP 50 MG B NO DRI1653BC ; HYDROCHLORIDE FOR | India | Zambia | 450 | |||
30049049 | DOCUMENT >> DOXILYD 50 DOXORUBICIN HCL INJ.50MG GROUP-B -SRL NO:1772 TAX DOCUMENT NO: 901993315 DT:29.08.2018 ; GR OUP-B ; 9019933 15 | India | Peru | 1400 | |||
30049049 | DOCUMENT >> DOXILYD 10 DOXORUBICIN HYDROCHLORIDE INJUSP 10MG GROUP-B -SRL NO:1772 TAX DOCUMENT NO:901992779DT:29.01.2018 ; INJ USP | India | Uzbekistan | 20510 | |||
30049049 | DOCUMENT >> DOXILYD 10 DOXORUBICIN HYDROCHLORIDE INJUSP 10MG GROUP-B -SRL NO:1772 TAX DOCUMENT NO:901992779DT:29.01.2018 ; INJ USP | India | Uzbekistan | 17740 | |||
30049049 | DOXORUBICIN >> DOXILYD 50 DOXORUBICIN INJ.50MG | India | Yemen | 5710 | 60 More Columns Available | ||
30049049 | DOCUMENT >> DOXILYD 50 DOXORUBICIN INJ.50MG GROUPB , SRL NO:1772 TAX DOCUMENT NO:901993290 DT 31.07.2018 ; GROUP B , | India | Uzbekistan | 7033 | |||
30049099 | PHARMACEUTICAL >> PHARMACEUTICAL MEDICINAL PHARMACEUTICAL MEDICINAL PRODUCTS- DOXILYD 50MG INJ DOXORUBICINE 50MG INJECTION BATCH NO.DRI1831BC MANUFACTURING .DT.JUN-18 E ; DOXIL YD | India | Malawi | 150 | |||
30049049 | INJECTION >> DOXILYD 50MG INJ. DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP 50MG TAX.INV.NO.CCB15591 DT. 28.03.2019 ; HYDROCHLOR IDE ; 50MG TAX.INV.NO.C CB15591 | India | Swaziland | 151 | |||
30049046 | DACTINOMYCIN >> BRAND DOXILYD GENERIC DOXORUBICINE 50MG ACTINOMYCIN D DACTINOMYCIN AND DOXORUBI CIN ; 50MG ACTINOMYCIN | India | Cameroon | 200 | |||
30049049 | DOCUMENT >> CELON DOXILYD 50 DOXORUBICIN HCL INJ.50MG GROUP-B -SRL NO:1772 TAX DOCUMENT NO:901993767 DT:30.04.2019 ; INJ.50M G GROUP-B ; NO:90 1993767 | India | Nigeria | 1000 | |||
30049049 | VIAL >> DOXILYD 50 DOXORUBICIN 1 VIAL | India | Zimbabwe | 26 | |||
30049046 | DOXILYD >> CELON DOXILYD CELON DOXILYD 10 | India | Lebanon | 7600 | |||
30049046 | DOXORUBICIN >> DOXILYD 10MG DOXORUBICIN INJ 10MG ROOMTEMPERATURE ; ROOM TEMPERATURE | India | Bhutan | 1600 | |||
30049046 | DOXORUBICIN >> DOXILYD 50 DOXORUBICIN HCL INJ.50MG | India | Peru | 1700 | |||
30049049 | DOCUMENT >> DOXILYD 10 DOXORUBICIN INJ.10MG GROUP-BSRL NO:1772 TAX DOCUMENT .NO:901994294 D T:25.02.2020 ; GROUP-B SRL | India | Philippines | 1200 | |||
30049099 | DOXILYD >> ** DOXILYD 10 INJ BATCH NO DRI2023AC MANUFACTURING DT MAY-20 EXP DT APR-22 ; MANUFACTURING DT | India | Sri Lanka | 50 | |||
30049099 | INJECTION >> Doxorubicin Hydrochloride for InjectionUSP 10mg-Doxilyd-10 ; Injection USP | India | Yemen | 1900 | |||
30049049 | GENERIC >> DOXILYD 50MG GENERIC NAME DOXORUBICIN 50MG BATCH NO.DRI2005BC EXP DT.12-202 1 | India | Mexico | 46 | |||
30049049 | DOCUMENT >> DOXILYD 50 DOXORUBICIN INJ.50MG GROUP-BSRL NO:1772 TAX DOCUMENT .NO:901994334 D T:29.02.2020 ; GROUP-B SRL | India | Philippines | 1400 | |||
30049046 | DOXORUBICIN >> DOXILYD 10 DOXORUBICIN HCL INJ.10MG GROUP-B -SRL NO:1769 TAX DOCUMENT NO:901994604 DT:15.09.2020 ; INJ.10MG GRO UP-B ; D T:15.09.2020 | India | Philippines | 441 | |||
30049046 | DOXORUBICIN >> DOXILYD 10 CEN DOXORUBICIN HCL INJ 10MG | India | Peru | 3200 | |||
30049046 | DOXORUBICIN >> CELON DOXILYD 50 DOXORUBICIN INJ.50MG GROUP-B -SRL NO:1769 TAX DOCUMENT NO:901994658 DT:26.10.2020 ; INJ.50MG G ROUP-B ; NO:901994 658 | India | Nigeria | 2000 | |||
30043990 | INJECTION >> INJECTION VIAL DOXILYD 50 MG INJECTION VIAL DOXORUBICIN HYDROCHLORIDE INJ USP 50 MG FREE SAMPLE DOXILYD 50 MG INJECTION QTY 3 NOS ; DOXORUBI CIN ; S AMPLE | India | Mauritius | 27 | |||
30049049 | GENERIC >> DOXILYD 50MG GENERIC NAME DOXORUBICIN 50MG BATCH NO.DRI2017BC EXP DT.04-202 2 | India | Mexico | 300 | |||
30049046 | DOXORUBICIN >> DOXILYD 10 DOXORUBICIN INJ. 10MG BATCH NO: DRI2045AC MANUFACTURING DT: 09-2020 EXP DT: 08-2022. INV. Nos: 901994686 , 901994688 ; N O: ; 08- 2022. | India | Egypt | 1900 | |||
30049046 | DOXORUBICIN >> DOXORUBICIN DOXILYD DOXORUBICIN DOXILYD 50 50MG INJECTI | India | Uganda | 100 | |||
30049049 | DOXORUBICIN >> DOXILYD 50 DOXORUBICIN INJ. 50MG B.NO.DR | India | Togo | 40 | |||
30049099 | INJECTION >> DOXORUBICIN INJECTION DOXILYD 50 DOXORUBICIN INJECTION USP 50MG 1 X 50 MG ENGLISH CELON LABS ; 50 MG 30049099 HSN | India | El Salvador | 500 | |||
30049046 | DOXORUBICIN >> CELON DOXILYD 50 DOXORUBICIN HCL INJ.50MG ; INJ.50M G 30049046 HS Code | India | Nigeria | 1000 | |||
30049099 | INJECTION >> DOXORUBICIN INJECTION DOXILYD 50 DOXORUBICIN INJECTION 50 MG 30049099HSN | India | Ghana | 50 | |||
30049046 | DOXORUBICIN >> DOXILYD 10 DOXORUBICIN HCL INJ.10MG TAX DOCUMENT NO:901994768 DATE:09-02-2021 ; TA X 30049046 HS Code | India | Peru | 200 | |||
30049046 | DOXORUBICIN >> DOXILYD 50 CEN DOXORUBICIN HCL INJ. 50M HS Code : 30049046 | India | Peru | 2500 | |||
30049099 | DOXILYD >> DOXILYD 50 HSN 30049099 | India | Zambia | 500 | |||
30049049 | GENERIC >> DOXILYD 50MG GENERIC NAME DOXORUBICIN BATCH NO.DRI2059BC EXP DT.11-2022 30049049 HS Code | India | Mexico | 105 | |||
30049046 | DOXORUBICIN >> DOXILYD 50 DOXORUBICIN HCL INJ. 50MG ASPER DOCUMENT ; AS PER 30049046 HSN | India | Myanmar | 3000 | |||
30049046 | DOXORUBICIN >> DOXILYD 50 DOXORUBICIN HCL INJ.50MG ALONG WITH 2NOS OF FREE SAMPLES ; INJ.50MG ALON G 30049046 HSN | India | Philippines | 2100 | |||
30049046 | DOXORUBICIN >> DOXILYD 50 DOXORUBICIN HCL INJ.50MG LUT- | India | Namibia | 1500 | |||
30049046 | DOXORUBICIN >> DOXILYD 50 DOXORUBICIN INJ.50MG | India | Kenya | 1500 | |||
30049046 | DOXORUBICIN >> DOXILYD 50 DOXORUBICIN INJ.50MG | India | Kenya | 1500 | |||
30049049 | VIAL >> VIAL DOXORUBICIN DOXILYD 50MG INJ VIAL DOXORUBICIN | India | United States | 50 | |||
30049099 | DOXORUBICIN >> Doxilyd 50mg Doxorubicin | India | United States | 325 | |||
30049049 | DOCUMENT >> DOXILYD 50MG INJ TAX DOCUMENT S-545 DT.20.12. | India | United Arab Emirates | 100 | |||
30049049 | DOXORUBICIN >> DOXORUBICIN HYDROCHLORIDE DOXILYD 50MG DOXORUBICIN HYDROCHLORIDE HS Code : 30049049 | India | Belize | 1500 | |||
30049046 | DOXORUBICIN >> DOXILYD 10 DOXORUBICIN HCL INJ.10MG | India | Peru | 4000 | |||
30049099 | DOXORUBICIN >> DOXILYD 50MG INJ DOXORUBICIN | India | United States | 100 | |||
30049049 | DOXILYD >> DOXILYD 50 MG INJ | India | Maldives | 12 | |||
30049099 | DOXILYD 10 DOXORUBICIN HCL BATCH NO | India | Sudan | 200 | |||
30049046 | FINISHED GOODS DOXILYD 10DOXORUBICIN H | India | Jordan | 1895 | |||
30049099 | HARMLESS MEDICINE, DOXILYD 50 MG DOXORU | India | Venezuela | 15 | |||
30049046 | FINISHED GOODS DOXILYD 50DOXORUBICIN H | India | Jordan | 4725 | |||
30049099 | DOXILYD 10 DOXORUBICIN HCL BATCH NO | India | Sudan | 200 | |||
30049099 | HARMLESS MEDICINE, DOXILYD 10 MG DOXORU | India | Venezuela | 5 | |||
30049099 | DOXILYD 50 DOXORUBICIN HCL BATCH NO | India | Sudan | 400 | |||
30049099 | DOXILYD 50MG INJECTION EACH VIAL CONTAIN | India | Kenya | 10 | |||
30049099 | DOXILYD 50 DOXORUBICIN HCL BATCH NO | India | Sudan | 400 | |||
30049049 | INDIAN HARMLESS PRODUCT - DOXILYD 500MG, | India | Belize | 200 | |||
30049099 | DOXILYD 50MG DOXORUBICIN | India | Mexico | 88 | |||
30049099 | DOXILYD 50MG DOXORUBICIN | India | Mexico | 12 | |||
30049099 | DOXILYD 50MG DOXORUBICIN | India | Mexico | 12 | |||
30049099 | DOXILYD 50MG DOXORUBICIN | India | Mexico | 88 | |||
30049099 | DOXILYD 50MG DOXORUBICIN | India | Mexico | 12 | |||
30049099 | DOXILYD 50MG DOXORUBICIN | India | Mexico | 88 | |||
30049089000 | 1000 NOS DOXILYD 50 DOXORUBICIN HYDROCHLORIDE 50MG LYOPHILIZED POWDER FOR INJECTION (IV) (ROOM TEMPERATURE) (ATRIG REF NO 00011485 LTO LIC NO CDRR-NCR-74002 CPR REG NO DRP-2300 INS CERT NO 433800-21-2022-18-0105) | India | Philippines | 26.70 | |||
30049089000 | 250 NOS DOXILYD 10 DOXORUBICIN HYDROCHLORIDE 10MG LYOPHILIZED POWDER FOR INJECTION (IV) (ROOM TEMPERATURE) (ATRIG REF NO 00011485 LTO LIC NO CDRR-NCR-74002 CPR REG NO DRP-2299 INS CERT NO 433800-21-2022-18-0105) | India | Philippines | 6.75 | |||
30049099 | DOXILYD 50MG INJ | India | United States | 200 | |||
30049052 | DOXILYD 50 MG DOXORUBICIN ,PACK1 VIAL | India | United Arab Emirates | 50 | |||
30049046 | DOXILYD 50DOXORUBICIN HCL INJ.50MG | India | Philippines | 1000 | |||
30049046 | DOXILYD 10DOXORUBICIN HCL INJ.10MG | India | Philippines | 250 | |||
30049046 | PHARMACEUTICALS : DOXILYD 50 INJECTION | India | Kazakhstan | 2000 | |||
30049052 | DOXILYD 50 MG DOXORUBICIN ,PACK1 VIAL | India | United Arab Emirates | 50 | |||
30049052 | DOXILYD 50 MG DOXORUBICIN ,PACK1 VIAL | India | United Arab Emirates | 50 | |||
30049099000 | TOTAL OF 51 PCE - CANCER MEDICINES: DOXILYD 50 MG INJ CLADRIM INJ 10MG VIDAZA 100MF ING IKGDAR INJ 100-500MG TOP | India | Philippines | 1.43 | |||
30049089000 | 300 NOS DOXILYD 50 DOXORUBICIN HYDROCHLORIDE 50MG LYOPHILIZED POWDER FOR INJECTION (IV) (ROOM TEMPERATURE) ATRIG REF NO 00011186 LTO LIC NO CDRR-NCR-74002 CPR REG NO DRP-2300 INS CERT NO 433800-21-2022-18-0101 | India | Philippines | 7.90 | |||
30049052 | DOXILYD 50 MG DOXORUBICIN ,PACK1 VIAL | India | United Arab Emirates | 50 | |||
30049099 | DOXORUBICIN - DOXILYD 50 MG INJ 1*1 VIAL | India | Sri Lanka | 300 | |||
30049099 | DOXORUBICIN - DOXILYD 50 MG INJ 1*1 VIAL | India | Sri Lanka | 300 | |||
30049099 | DOXILYD 50 MG INJ 1*1 VIAL PACK 1'S | India | Sri Lanka | 300 | |||
30049052 | PHARMACEUTICALS : DOXILYD 50 INJECTION | India | Kazakhstan | 4000 | |||
30049052 | DOXILYD 50MG INJ DOXORUBICIN 50MG | India | Somalia | 20 | |||
3004902400 | DOXILYD 50 , DOXILYD 50 , S-M|LOTE: DRI2230BC; VENCE: MAYO. 2024|MEDICAMENTO PARA TRATAMIENTO ONCOLOGICO. PACKING: 1X1`S PACKS - VIALS|DOXORUBICIN HYDROCHLORIDE FOR INJECTION 50MG|ELABORADO POR CELON LABORATORIES PRIVATE LIMITED - INDIA | India | Peru | 5000 | |||
30049046 | DOXILYD 50DOXORUBICIN HCL INJ.50MG | India | Philippines | 300 | |||
30049046 | CELON DOXILYD 50 DOXORUBICIN HCL INJ USP | India | Nigeria | 5000 | |||
30049046 | DOXILYD 50 DOXORUBICIN HCL INJ.50MG | India | Kenya | 2000 | |||
3004902400 | DOXILYD 50 , DOXILYD 50 , S-M|LOTE: DRI2230BC; VENCE: MAYO. 2024|MEDICAMENTO PARA TRATAMIENTO ONCOLOGICO. PACKING: 1X1`S PACKS - VIALS|DOXORUBICIN HYDROCHLORIDE FOR INJECTION 50MG|ELABORADO POR CELON LABORATORIES PRIVATE LIMITED - INDIA | India | Peru | 5000 | |||
30049036 | HARMLESS GO ARTICLE / ODS / PRODUCT / ITEM DOXILYD 10 | India | Mexico | 100 | |||
30049052 | HARMLESS GO ARTICLE / ODS / PRODUCT / ITEM DOXILYD 50 | India | Mexico | 100 | |||
30049046 | DOXILYD 50DOXORUBICIN HCL INJECTION USP | India | Peru | 5000 | |||
30049089000 | 2000 NOS DOXILYD 50 DOXORUBICIN HYDROCHLORIDE 50MG LYOPHILIZED POWDER FOR INJECTION (IV) (ROOMTEMPERATURE) (ATRIG REF NO 00010815 LTO LIC NO CDRR-NCR-74002 CPR REG NO DRP-2300 INS POLICY NO 433800-21-2022-18-0094) | India | Philippines | 53.25 | |||
30049046 | DOXILYD 50DOXORUBICIN HCL INJ.50MG | India | Philippines | 2000 | |||
3004902400 | DOXILYD 10 , DOXILYD 10 , S-M|LOTE: DRI2220AC; VENCE: FEB-2024|MEDICAMENTO PARA TRATAMIENTO ONCOLOGICO|DOXORUBICIN HYDROCHLORIDE FOR INJECTION 10MG. PACKING: 1X1`S PACKS- VIALS|ELABORADO POR CELON LABORATORIES PRIVATE LIMITED - INDIA | India | Peru | 1000 | |||
3004902400 | DOXILYD 10 , DOXILYD 10 , S-M|LOTE: DRI2220AC; VENCE: FEB-2024|MEDICAMENTO PARA TRATAMIENTO ONCOLOGICO|DOXORUBICIN HYDROCHLORIDE FOR INJECTION 10MG. PACKING: 1X1`S PACKS- VIALS|ELABORADO POR CELON LABORATORIES PRIVATE LIMITED - INDIA | India | Peru | 1000 | |||
30049052 | PHARMACEUTICALS : DOXILYD 50 INJECTION | India | Kazakhstan | 2500 | |||
30049099 | Doxilyd 50mg | India | Nigeria | 100 | |||
30049099 | PHARMA ITEMS Doxilyd 50mg OTHER DETA | India | Nigeria | 100 | |||
30049099 | Doxilyd 50mg | India | Nigeria | 100 | |||
30049046 | DOXILYD 10DOXORUBICIN HCL INJ. 10MG | India | Peru | 1000 | |||
30049049 | PHARMA ITEMS- DOXILYD 50 MG OTHER DEAT | India | Cameroon | 100 | |||
30049089000 | 500 NOS DOXILYD 10 DOXORUBICIN HYDROCHLORIDE 10MG LYOPHILIZED POWDER FOR INJECTION (IV) (ROOM TEMPERATURE) (LTO LIC NO CDRR-NCR-74002 CPR REG NO DRP-2299 ATRIG REF NO 00010442 INS CERT NO 433800-21-2022-18-0073) | India | Philippines | 13.10 | |||
30049046 | DOXILYD 10 DOXORUBICIN HCL INJ.10MG | India | Philippines | 500 |
HSN Code | Product Description | Origin | Destination | Qty. | Importer | Exporter |
---|
29331990 | HYDROCHLORIDE >> DOXORUBICIN HYDROCHLORIDEFOR DOXILYD 50 MG DOXORUBICIN HYDROCHLORIDEFOR INJ USP 50 MG B NO DRI1653BC ; HYDROCHLORIDE FOR | India | Zambia | 450 | |||
30049049 | DOCUMENT >> DOXILYD 50 DOXORUBICIN HCL INJ.50MG GROUP-B -SRL NO:1772 TAX DOCUMENT NO: 901993315 DT:29.08.2018 ; GR OUP-B ; 9019933 15 | India | Peru | 1400 | |||
30049049 | DOCUMENT >> DOXILYD 10 DOXORUBICIN HYDROCHLORIDE INJUSP 10MG GROUP-B -SRL NO:1772 TAX DOCUMENT NO:901992779DT:29.01.2018 ; INJ USP | India | Uzbekistan | 20510 | |||
30049049 | DOCUMENT >> DOXILYD 10 DOXORUBICIN HYDROCHLORIDE INJUSP 10MG GROUP-B -SRL NO:1772 TAX DOCUMENT NO:901992779DT:29.01.2018 ; INJ USP | India | Uzbekistan | 17740 | |||
30049049 | DOXORUBICIN >> DOXILYD 50 DOXORUBICIN INJ.50MG | India | Yemen | 5710 | 60 More Columns Available | ||
30049049 | DOCUMENT >> DOXILYD 50 DOXORUBICIN INJ.50MG GROUPB , SRL NO:1772 TAX DOCUMENT NO:901993290 DT 31.07.2018 ; GROUP B , | India | Uzbekistan | 7033 | |||
30049099 | PHARMACEUTICAL >> PHARMACEUTICAL MEDICINAL PHARMACEUTICAL MEDICINAL PRODUCTS- DOXILYD 50MG INJ DOXORUBICINE 50MG INJECTION BATCH NO.DRI1831BC MANUFACTURING .DT.JUN-18 E ; DOXIL YD | India | Malawi | 150 | |||
30049049 | INJECTION >> DOXILYD 50MG INJ. DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP 50MG TAX.INV.NO.CCB15591 DT. 28.03.2019 ; HYDROCHLOR IDE ; 50MG TAX.INV.NO.C CB15591 | India | Swaziland | 151 | |||
30049046 | DACTINOMYCIN >> BRAND DOXILYD GENERIC DOXORUBICINE 50MG ACTINOMYCIN D DACTINOMYCIN AND DOXORUBI CIN ; 50MG ACTINOMYCIN | India | Cameroon | 200 | |||
30049049 | DOCUMENT >> CELON DOXILYD 50 DOXORUBICIN HCL INJ.50MG GROUP-B -SRL NO:1772 TAX DOCUMENT NO:901993767 DT:30.04.2019 ; INJ.50M G GROUP-B ; NO:90 1993767 | India | Nigeria | 1000 | |||
30049049 | VIAL >> DOXILYD 50 DOXORUBICIN 1 VIAL | India | Zimbabwe | 26 | |||
30049046 | DOXILYD >> CELON DOXILYD CELON DOXILYD 10 | India | Lebanon | 7600 | |||
30049046 | DOXORUBICIN >> DOXILYD 10MG DOXORUBICIN INJ 10MG ROOMTEMPERATURE ; ROOM TEMPERATURE | India | Bhutan | 1600 | |||
30049046 | DOXORUBICIN >> DOXILYD 50 DOXORUBICIN HCL INJ.50MG | India | Peru | 1700 | |||
30049049 | DOCUMENT >> DOXILYD 10 DOXORUBICIN INJ.10MG GROUP-BSRL NO:1772 TAX DOCUMENT .NO:901994294 D T:25.02.2020 ; GROUP-B SRL | India | Philippines | 1200 | |||
30049099 | DOXILYD >> ** DOXILYD 10 INJ BATCH NO DRI2023AC MANUFACTURING DT MAY-20 EXP DT APR-22 ; MANUFACTURING DT | India | Sri Lanka | 50 | |||
30049099 | INJECTION >> Doxorubicin Hydrochloride for InjectionUSP 10mg-Doxilyd-10 ; Injection USP | India | Yemen | 1900 | |||
30049049 | GENERIC >> DOXILYD 50MG GENERIC NAME DOXORUBICIN 50MG BATCH NO.DRI2005BC EXP DT.12-202 1 | India | Mexico | 46 | |||
30049049 | DOCUMENT >> DOXILYD 50 DOXORUBICIN INJ.50MG GROUP-BSRL NO:1772 TAX DOCUMENT .NO:901994334 D T:29.02.2020 ; GROUP-B SRL | India | Philippines | 1400 | |||
30049046 | DOXORUBICIN >> DOXILYD 10 DOXORUBICIN HCL INJ.10MG GROUP-B -SRL NO:1769 TAX DOCUMENT NO:901994604 DT:15.09.2020 ; INJ.10MG GRO UP-B ; D T:15.09.2020 | India | Philippines | 441 | |||
30049046 | DOXORUBICIN >> DOXILYD 10 CEN DOXORUBICIN HCL INJ 10MG | India | Peru | 3200 | |||
30049046 | DOXORUBICIN >> CELON DOXILYD 50 DOXORUBICIN INJ.50MG GROUP-B -SRL NO:1769 TAX DOCUMENT NO:901994658 DT:26.10.2020 ; INJ.50MG G ROUP-B ; NO:901994 658 | India | Nigeria | 2000 | |||
30043990 | INJECTION >> INJECTION VIAL DOXILYD 50 MG INJECTION VIAL DOXORUBICIN HYDROCHLORIDE INJ USP 50 MG FREE SAMPLE DOXILYD 50 MG INJECTION QTY 3 NOS ; DOXORUBI CIN ; S AMPLE | India | Mauritius | 27 | |||
30049049 | GENERIC >> DOXILYD 50MG GENERIC NAME DOXORUBICIN 50MG BATCH NO.DRI2017BC EXP DT.04-202 2 | India | Mexico | 300 | |||
30049046 | DOXORUBICIN >> DOXILYD 10 DOXORUBICIN INJ. 10MG BATCH NO: DRI2045AC MANUFACTURING DT: 09-2020 EXP DT: 08-2022. INV. Nos: 901994686 , 901994688 ; N O: ; 08- 2022. | India | Egypt | 1900 | |||
30049046 | DOXORUBICIN >> DOXORUBICIN DOXILYD DOXORUBICIN DOXILYD 50 50MG INJECTI | India | Uganda | 100 | |||
30049049 | DOXORUBICIN >> DOXILYD 50 DOXORUBICIN INJ. 50MG B.NO.DR | India | Togo | 40 | |||
30049099 | INJECTION >> DOXORUBICIN INJECTION DOXILYD 50 DOXORUBICIN INJECTION USP 50MG 1 X 50 MG ENGLISH CELON LABS ; 50 MG 30049099 HSN | India | El Salvador | 500 | |||
30049046 | DOXORUBICIN >> CELON DOXILYD 50 DOXORUBICIN HCL INJ.50MG ; INJ.50M G 30049046 HS Code | India | Nigeria | 1000 | |||
30049099 | INJECTION >> DOXORUBICIN INJECTION DOXILYD 50 DOXORUBICIN INJECTION 50 MG 30049099HSN | India | Ghana | 50 | |||
30049046 | DOXORUBICIN >> DOXILYD 10 DOXORUBICIN HCL INJ.10MG TAX DOCUMENT NO:901994768 DATE:09-02-2021 ; TA X 30049046 HS Code | India | Peru | 200 | |||
30049046 | DOXORUBICIN >> DOXILYD 50 CEN DOXORUBICIN HCL INJ. 50M HS Code : 30049046 | India | Peru | 2500 | |||
30049099 | DOXILYD >> DOXILYD 50 HSN 30049099 | India | Zambia | 500 | |||
30049049 | GENERIC >> DOXILYD 50MG GENERIC NAME DOXORUBICIN BATCH NO.DRI2059BC EXP DT.11-2022 30049049 HS Code | India | Mexico | 105 | |||
30049046 | DOXORUBICIN >> DOXILYD 50 DOXORUBICIN HCL INJ. 50MG ASPER DOCUMENT ; AS PER 30049046 HSN | India | Myanmar | 3000 | |||
30049046 | DOXORUBICIN >> DOXILYD 50 DOXORUBICIN HCL INJ.50MG ALONG WITH 2NOS OF FREE SAMPLES ; INJ.50MG ALON G 30049046 HSN | India | Philippines | 2100 | |||
30049046 | DOXORUBICIN >> DOXILYD 50 DOXORUBICIN HCL INJ.50MG LUT- | India | Namibia | 1500 | |||
30049046 | DOXORUBICIN >> DOXILYD 50 DOXORUBICIN INJ.50MG | India | Kenya | 1500 | |||
30049046 | DOXORUBICIN >> DOXILYD 50 DOXORUBICIN INJ.50MG | India | Kenya | 1500 | |||
30049049 | VIAL >> VIAL DOXORUBICIN DOXILYD 50MG INJ VIAL DOXORUBICIN | India | United States | 50 | |||
30049099 | DOXORUBICIN >> Doxilyd 50mg Doxorubicin | India | United States | 325 | |||
30049049 | DOCUMENT >> DOXILYD 50MG INJ TAX DOCUMENT S-545 DT.20.12. | India | United Arab Emirates | 100 | |||
30049049 | DOXORUBICIN >> DOXORUBICIN HYDROCHLORIDE DOXILYD 50MG DOXORUBICIN HYDROCHLORIDE HS Code : 30049049 | India | Belize | 1500 | |||
30049046 | DOXORUBICIN >> DOXILYD 10 DOXORUBICIN HCL INJ.10MG | India | Peru | 4000 | |||
30049099 | DOXORUBICIN >> DOXILYD 50MG INJ DOXORUBICIN | India | United States | 100 | |||
30049049 | DOXILYD >> DOXILYD 50 MG INJ | India | Maldives | 12 | |||
30049099 | DOXILYD 10 DOXORUBICIN HCL BATCH NO | India | Sudan | 200 | |||
30049046 | FINISHED GOODS DOXILYD 10DOXORUBICIN H | India | Jordan | 1895 | |||
30049099 | HARMLESS MEDICINE, DOXILYD 50 MG DOXORU | India | Venezuela | 15 | |||
30049046 | FINISHED GOODS DOXILYD 50DOXORUBICIN H | India | Jordan | 4725 | |||
30049099 | DOXILYD 10 DOXORUBICIN HCL BATCH NO | India | Sudan | 200 | |||
30049099 | HARMLESS MEDICINE, DOXILYD 10 MG DOXORU | India | Venezuela | 5 | |||
30049099 | DOXILYD 50 DOXORUBICIN HCL BATCH NO | India | Sudan | 400 | |||
30049099 | DOXILYD 50MG INJECTION EACH VIAL CONTAIN | India | Kenya | 10 | |||
30049099 | DOXILYD 50 DOXORUBICIN HCL BATCH NO | India | Sudan | 400 | |||
30049049 | INDIAN HARMLESS PRODUCT - DOXILYD 500MG, | India | Belize | 200 | |||
30049099 | DOXILYD 50MG DOXORUBICIN | India | Mexico | 88 | |||
30049099 | DOXILYD 50MG DOXORUBICIN | India | Mexico | 12 | |||
30049099 | DOXILYD 50MG DOXORUBICIN | India | Mexico | 12 | |||
30049099 | DOXILYD 50MG DOXORUBICIN | India | Mexico | 88 | |||
30049099 | DOXILYD 50MG DOXORUBICIN | India | Mexico | 12 | |||
30049099 | DOXILYD 50MG DOXORUBICIN | India | Mexico | 88 | |||
30049089000 | 1000 NOS DOXILYD 50 DOXORUBICIN HYDROCHLORIDE 50MG LYOPHILIZED POWDER FOR INJECTION (IV) (ROOM TEMPERATURE) (ATRIG REF NO 00011485 LTO LIC NO CDRR-NCR-74002 CPR REG NO DRP-2300 INS CERT NO 433800-21-2022-18-0105) | India | Philippines | 26.70 | |||
30049089000 | 250 NOS DOXILYD 10 DOXORUBICIN HYDROCHLORIDE 10MG LYOPHILIZED POWDER FOR INJECTION (IV) (ROOM TEMPERATURE) (ATRIG REF NO 00011485 LTO LIC NO CDRR-NCR-74002 CPR REG NO DRP-2299 INS CERT NO 433800-21-2022-18-0105) | India | Philippines | 6.75 | |||
30049099 | DOXILYD 50MG INJ | India | United States | 200 | |||
30049052 | DOXILYD 50 MG DOXORUBICIN ,PACK1 VIAL | India | United Arab Emirates | 50 | |||
30049046 | DOXILYD 50DOXORUBICIN HCL INJ.50MG | India | Philippines | 1000 | |||
30049046 | DOXILYD 10DOXORUBICIN HCL INJ.10MG | India | Philippines | 250 | |||
30049046 | PHARMACEUTICALS : DOXILYD 50 INJECTION | India | Kazakhstan | 2000 | |||
30049052 | DOXILYD 50 MG DOXORUBICIN ,PACK1 VIAL | India | United Arab Emirates | 50 | |||
30049052 | DOXILYD 50 MG DOXORUBICIN ,PACK1 VIAL | India | United Arab Emirates | 50 | |||
30049099000 | TOTAL OF 51 PCE - CANCER MEDICINES: DOXILYD 50 MG INJ CLADRIM INJ 10MG VIDAZA 100MF ING IKGDAR INJ 100-500MG TOP | India | Philippines | 1.43 | |||
30049089000 | 300 NOS DOXILYD 50 DOXORUBICIN HYDROCHLORIDE 50MG LYOPHILIZED POWDER FOR INJECTION (IV) (ROOM TEMPERATURE) ATRIG REF NO 00011186 LTO LIC NO CDRR-NCR-74002 CPR REG NO DRP-2300 INS CERT NO 433800-21-2022-18-0101 | India | Philippines | 7.90 | |||
30049052 | DOXILYD 50 MG DOXORUBICIN ,PACK1 VIAL | India | United Arab Emirates | 50 | |||
30049099 | DOXORUBICIN - DOXILYD 50 MG INJ 1*1 VIAL | India | Sri Lanka | 300 | |||
30049099 | DOXORUBICIN - DOXILYD 50 MG INJ 1*1 VIAL | India | Sri Lanka | 300 | |||
30049099 | DOXILYD 50 MG INJ 1*1 VIAL PACK 1'S | India | Sri Lanka | 300 | |||
30049052 | PHARMACEUTICALS : DOXILYD 50 INJECTION | India | Kazakhstan | 4000 | |||
30049052 | DOXILYD 50MG INJ DOXORUBICIN 50MG | India | Somalia | 20 | |||
3004902400 | DOXILYD 50 , DOXILYD 50 , S-M|LOTE: DRI2230BC; VENCE: MAYO. 2024|MEDICAMENTO PARA TRATAMIENTO ONCOLOGICO. PACKING: 1X1`S PACKS - VIALS|DOXORUBICIN HYDROCHLORIDE FOR INJECTION 50MG|ELABORADO POR CELON LABORATORIES PRIVATE LIMITED - INDIA | India | Peru | 5000 | |||
30049046 | DOXILYD 50DOXORUBICIN HCL INJ.50MG | India | Philippines | 300 | |||
30049046 | CELON DOXILYD 50 DOXORUBICIN HCL INJ USP | India | Nigeria | 5000 | |||
30049046 | DOXILYD 50 DOXORUBICIN HCL INJ.50MG | India | Kenya | 2000 | |||
3004902400 | DOXILYD 50 , DOXILYD 50 , S-M|LOTE: DRI2230BC; VENCE: MAYO. 2024|MEDICAMENTO PARA TRATAMIENTO ONCOLOGICO. PACKING: 1X1`S PACKS - VIALS|DOXORUBICIN HYDROCHLORIDE FOR INJECTION 50MG|ELABORADO POR CELON LABORATORIES PRIVATE LIMITED - INDIA | India | Peru | 5000 | |||
30049036 | HARMLESS GO ARTICLE / ODS / PRODUCT / ITEM DOXILYD 10 | India | Mexico | 100 | |||
30049052 | HARMLESS GO ARTICLE / ODS / PRODUCT / ITEM DOXILYD 50 | India | Mexico | 100 | |||
30049046 | DOXILYD 50DOXORUBICIN HCL INJECTION USP | India | Peru | 5000 | |||
30049089000 | 2000 NOS DOXILYD 50 DOXORUBICIN HYDROCHLORIDE 50MG LYOPHILIZED POWDER FOR INJECTION (IV) (ROOMTEMPERATURE) (ATRIG REF NO 00010815 LTO LIC NO CDRR-NCR-74002 CPR REG NO DRP-2300 INS POLICY NO 433800-21-2022-18-0094) | India | Philippines | 53.25 | |||
30049046 | DOXILYD 50DOXORUBICIN HCL INJ.50MG | India | Philippines | 2000 | |||
3004902400 | DOXILYD 10 , DOXILYD 10 , S-M|LOTE: DRI2220AC; VENCE: FEB-2024|MEDICAMENTO PARA TRATAMIENTO ONCOLOGICO|DOXORUBICIN HYDROCHLORIDE FOR INJECTION 10MG. PACKING: 1X1`S PACKS- VIALS|ELABORADO POR CELON LABORATORIES PRIVATE LIMITED - INDIA | India | Peru | 1000 | |||
3004902400 | DOXILYD 10 , DOXILYD 10 , S-M|LOTE: DRI2220AC; VENCE: FEB-2024|MEDICAMENTO PARA TRATAMIENTO ONCOLOGICO|DOXORUBICIN HYDROCHLORIDE FOR INJECTION 10MG. PACKING: 1X1`S PACKS- VIALS|ELABORADO POR CELON LABORATORIES PRIVATE LIMITED - INDIA | India | Peru | 1000 | |||
30049052 | PHARMACEUTICALS : DOXILYD 50 INJECTION | India | Kazakhstan | 2500 | |||
30049099 | Doxilyd 50mg | India | Nigeria | 100 | |||
30049099 | PHARMA ITEMS Doxilyd 50mg OTHER DETA | India | Nigeria | 100 | |||
30049099 | Doxilyd 50mg | India | Nigeria | 100 | |||
30049046 | DOXILYD 10DOXORUBICIN HCL INJ. 10MG | India | Peru | 1000 | |||
30049049 | PHARMA ITEMS- DOXILYD 50 MG OTHER DEAT | India | Cameroon | 100 | |||
30049089000 | 500 NOS DOXILYD 10 DOXORUBICIN HYDROCHLORIDE 10MG LYOPHILIZED POWDER FOR INJECTION (IV) (ROOM TEMPERATURE) (LTO LIC NO CDRR-NCR-74002 CPR REG NO DRP-2299 ATRIG REF NO 00010442 INS CERT NO 433800-21-2022-18-0073) | India | Philippines | 13.10 | |||
30049046 | DOXILYD 10 DOXORUBICIN HCL INJ.10MG | India | Philippines | 500 |
Volza's data of India Doxilyd exports allows you to study detailed data with buyer supplier names for last 10 years.
Volza's data of India Doxilyd exports helps you create a export strategy from detailed trade data with buyer supplier names, price, volume for last 10 years.
You can find India Doxilyd export market intelligence of last 10 years with buyer, supplier, price and volume from volza.com
You can find New markets for Doxilyd exports from Volza Country wise market report of last 10 years with growth rate, buyer, supplier, price and volume.
Top 5 HSN codes for Doxilyd are HSN Code 30049046 , HSN Code 30049049 , HSN Code 3004902400, HSN Code 30049099, HSN Code 30049089000, You can check for details at https://www.volza.com/hs-codes.
Volza's data of India Doxilyd exports is 100% authentic as it is based on actual export import shipments and is collected globally from over 20,000 ports from over 70+ Countries.
Data of India Doxilyd exports contains strategic information and is very useful for exporters and importers who want to expand global trade, improve supply chain of Doxilyd, find economical vendors, new buyers and fast growing markets.
Data of India Doxilyd exports contains date of shipment, Name and contact details of exporter, importer, product description, price, quantity, country & port of origin, country & port of destination and many other fields.
We update information of India Doxilyd exports every month.
As per the Volza's India export data of Doxilyd, Peru accounted for maximum share with 195 shipments followed by Philippines with 82 and Mexico at 3rd spot with 39 shipments.
You can download latest data of May-2024 of India Doxilyd exports here
You can download Volza India Doxilyd export data with names of buyers and suppliers.
There are two options to Subscribe, Online Access starts at $1500 and reports from Volza Consulting starts at $1000.
Volza Sales team will be happy to answer your questions, you can reach us at [email protected] or +1-302 786 5213.
Online |
---|
Mode Do it yourself |
Availiblity Instant access |
Cost Access 209+ countries data |
Payment Instant Online |
Data Format Excel |
View More |
Volza Consulting |
---|
Mode Customer Order |
Availiblity Starts within 48 hours |
Cost $1000 |
Payment Online and other modes |
Data Format Excel, SQL, MSAcess & Custom |
View More |
Support
Important Links
Partners
Trade Data
About Us
Partners